6-(3,4-Diaminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one, 95.0%, 1g

4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy}piperidine, 95%, 500mg

2-Bromo-1,3-dichloro-4-(trifluoromethyl)benzene, 98%, 250mg

N-(3-bromopropyl)methanesulfonamide, 95.0%, 500mg

3-Bromo-6-fluorophthalic acid, 98%, 1g

2-Methoxy-5-(trifluoromethoxy)benzamide, 1g

3-(4-Chlorophenyl)pentanedioic acid, 98.0%, 5g

(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate, 95.0%, 250mg

(R)-3-((tert-Butoxycarbonyl)amino)-5-(methylthio)pentanoic acid, 95.0%, 1g

6-Chloro[1,3]dioxolo[4,5-f][1,3]benzothiazole, 95.0%, 250mg

Colonna capillare per GC ROTI®Cap-5, 50 m, 0,25 mm, 0,25 µm, 1 Pezzo(i)

Adamantan-2-one, 98.00%, 250g

3-(Piperidin-1-yl)propan-1-ol>98.0%(GC)1g